<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02496052</url>
  </required_header>
  <id_info>
    <org_study_id>NO.1-20140601</org_study_id>
    <secondary_id>2014-1-2112</secondary_id>
    <secondary_id>zylx201406</secondary_id>
    <nct_id>NCT02496052</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions</brief_title>
  <official_title>The Efficacy and Safety of the Dried Biological Amnion Graft Following Hysteroscopic Lysis for the Prevention of Postoperative Adhesions in Patients With Intrauterine Adhesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Obstetrics and Gynecology Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Obstetrics and Gynecology Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To estimate the efficacy and safety of dried biological amnion graft after hysteroscopic
      lysis of intrauterine adhesions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model:
      Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>second diagnostic hysteroscopy</measure>
    <time_frame>postoperation three to four months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Intrauterine Adhesions</condition>
  <arm_group>
    <arm_group_label>dried biological amnion graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients, who are with IUA, treated by uterine application of amnion membrane + Foley balloon+ hormones (estradiol valerate tablets+dydrogesterone Tablets) following hysteroscopic adhesiolysis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foley catheter balloon only</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients, who are with IUA, treated by uterine application of Foley balloon only+ hormones (estradiol valerate tablets+dydrogesterone Tablets) following hysteroscopic adhesiolysis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>dried biological amnion graft</intervention_name>
    <description>Uterine application of amnion membrane following hysteroscopic adhesiolysis. Other Name: Human amnion membrane</description>
    <arm_group_label>dried biological amnion graft</arm_group_label>
    <other_name>Uterine application of amnion membrane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Foley balloon</intervention_name>
    <description>Device: Foley balloon Uterine application of Foley balloon</description>
    <arm_group_label>dried biological amnion graft</arm_group_label>
    <arm_group_label>Foley catheter balloon only</arm_group_label>
    <other_name>Device: Foley balloon Uterine application of Foley balloon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>estradiol valerate tablets+dydrogesterone Tablets</intervention_name>
    <description>oral estradiol valerate tablets+dydrogesterone Tablets</description>
    <arm_group_label>dried biological amnion graft</arm_group_label>
    <arm_group_label>Foley catheter balloon only</arm_group_label>
    <other_name>Progynova+dydrogesterone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 20-40 years；

          -  previously diagnostic hysteroscopy confirmed adhesion score &gt;5， according to the
             American Fertility Society （AFS）classification of IUA；

          -  complains of menstruation disorder and reproductive dysfunction；

          -  informed consent.

        Exclusion Criteria:

          -  premature menopause,

          -  presence of other intrauterine lesions (e.g. polyps, myoma, septa), and

          -  presence of severe intercurrent illness (e.g. systemic disease, coagulative disorders,
             severe kidney and liver diseases),

          -  adhesions limited to the lower uterine cavity or the cervical canal.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Duan Hua, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Obstetrics and Gynecology Hospital, Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wang Xin, MD</last_name>
    <phone>13681401510</phone>
    <email>wx_0327@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gan Lu, MD</last_name>
    <phone>13552320665</phone>
    <email>gl19880508@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Obstetrics and Gynecology Hospital，Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liu Zhen, M.D</last_name>
      <phone>+8613718210767</phone>
      <email>fcyykyb@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Amer MI, Abd-El-Maeboud KH. Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res. 2006 Dec;32(6):559-66.</citation>
    <PMID>17100817</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2015</study_first_submitted>
  <study_first_submitted_qc>July 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2015</study_first_posted>
  <last_update_submitted>July 15, 2015</last_update_submitted>
  <last_update_submitted_qc>July 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amnion graft</keyword>
  <keyword>New biological barrier system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estradiol</mesh_term>
    <mesh_term>Polyestradiol phosphate</mesh_term>
    <mesh_term>Dydrogesterone</mesh_term>
    <mesh_term>Estradiol 3-benzoate</mesh_term>
    <mesh_term>Estradiol 17 beta-cypionate</mesh_term>
    <mesh_term>Estradiol valerate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

